{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-012294","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.749517+00:00","generated_at":"2026-05-27T10:46:21.291727+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Soleno Therapeutics raises executive base salaries, grants FY2024 bonuses and equity awards","bullets":["CEO Bhatnagar base salary increased to $739,000 effective Jan 1, 2025; FY2024 cash bonus of $403,200.","CFO Mackaness base salary set at $511,000; FY2024 bonus of $193,200; 31,000 options and 14,500 RSUs awarded.","SVP Hirano base salary $432,000; FY2024 bonus $137,812; 13,800 options and 6,400 RSUs awarded.","Options vest over 4 years (monthly after 1-year cliff); RSUs vest 25% per year over 4 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-012294","json":"https://secwatch.observer/filing/0001193125-25-012294.json","markdown":"https://secwatch.observer/filing/0001193125-25-012294.md","text":"https://secwatch.observer/filing/0001193125-25-012294.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312525012294/0001193125-25-012294-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312525012294/d913677d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T10:46:21.291727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}